Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
53,599,048
-
Total 13F shares
-
34,986,278
-
Share change
-
+3,520,894
-
Total reported value
-
$1,496,099,350
-
Put/Call ratio
-
24%
-
Price per share
-
$42.80
-
Number of holders
-
100
-
Value change
-
+$151,053,440
-
Number of buys
-
69
-
Number of sells
-
27
Institutional Holders of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) as of Q1 2024
As of 31 Mar 2024 SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) had 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,986,278 shares of stock of the company.
Largest 10 holders included Vivo Capital, LLC, Carlyle Group Inc., PERCEPTIVE ADVISORS LLC, JANUS HENDERSON GROUP PLC, Nantahala Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Avoro Capital Advisors LLC, Vestal Point Capital, LP, STATE STREET CORP, and VANGUARD GROUP INC.
This table shows 97 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.